Technical Analysis for BFRI - Biofrontera Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 1.54 | -3.75% | -0.06 |
BFRI closed down 3.75 percent on Wednesday, May 8, 2024, on 27 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It was able to find support at its 50 day moving average.
Earnings due: May 15
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 50 DMA Support | Bullish | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| 20 DMA Resistance | Bearish | -3.75% | |
| 50 DMA Support | Bullish | -3.75% | |
| Wide Bands | Range Expansion | -3.75% | |
| 20 DMA Resistance | Bearish | -10.47% | |
| Wide Bands | Range Expansion | -10.47% | |
| 20 DMA Resistance | Bearish | -10.47% | |
| Wide Bands | Range Expansion | -10.47% |
| Alert | Time |
|---|---|
| 50 DMA Support | about 8 hours ago |
| Down 5% | about 8 hours ago |
| Fell Below Previous Day's Low | about 8 hours ago |
| Down 3% | about 8 hours ago |
| Possible NR7 | about 9 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/15/2024
Biofrontera Inc., a biopharmaceutical company, develops and provides dermatological products for the treatment of skin diseases in the United States. It primarily develops therapies for non-melanoma skin cancer. It offers Ameluz, an aminolevulinic acid hydrochloride gel for the photodynamic therapy of actinic keratoses; and BF-RhodoLED, an LED lamp emitting red light for use in photodynamic therapy. The company was founded in 1997 and is based in Woburn, Massachusetts.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Biopharmaceutical Clinical Medicine Health Sciences Melanoma Antineoplastic Drugs Dermatology Medical Physics Laser Medicine Skin Diseases Light Therapy Treatment Of Skin Diseases Actinic Keratosis Non Melanoma Skin Cancer
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Biopharmaceutical Clinical Medicine Health Sciences Melanoma Antineoplastic Drugs Dermatology Medical Physics Laser Medicine Skin Diseases Light Therapy Treatment Of Skin Diseases Actinic Keratosis Non Melanoma Skin Cancer
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 13.42 |
| 52 Week Low | 0.61 |
| Average Volume | 132,094 |
| 200-Day Moving Average | 4.36 |
| 50-Day Moving Average | 1.53 |
| 20-Day Moving Average | 1.72 |
| 10-Day Moving Average | 1.72 |
| Average True Range | 0.24 |
| RSI (14) | 45.65 |
| ADX | 17.97 |
| +DI | 22.87 |
| -DI | 19.78 |
| Chandelier Exit (Long, 3 ATRs) | 1.72 |
| Chandelier Exit (Short, 3 ATRs) | 2.09 |
| Upper Bollinger Bands | 2.04 |
| Lower Bollinger Band | 1.40 |
| Percent B (%b) | 0.22 |
| BandWidth | 37.00 |
| MACD Line | 0.02 |
| MACD Signal Line | 0.05 |
| MACD Histogram | -0.0319 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.72 | ||||
| Resistance 3 (R3) | 1.73 | 1.67 | 1.69 | ||
| Resistance 2 (R2) | 1.67 | 1.63 | 1.67 | 1.68 | |
| Resistance 1 (R1) | 1.61 | 1.60 | 1.58 | 1.60 | 1.67 |
| Pivot Point | 1.55 | 1.55 | 1.54 | 1.55 | 1.55 |
| Support 1 (S1) | 1.49 | 1.51 | 1.46 | 1.48 | 1.41 |
| Support 2 (S2) | 1.43 | 1.48 | 1.43 | 1.40 | |
| Support 3 (S3) | 1.37 | 1.43 | 1.39 | ||
| Support 4 (S4) | 1.36 |
